Hydrazine (Hz) is a toxic and hazardous metabolite of isoniazid (INH) causing fatty liver and liver necrosis, and it is also a mutagen and a carcinogen.2,3) It has been detected by gas chromatography-mass spectrometry (GC-MS) in the urine of INH-dosed patients with tuberculosis.4) It is also well-known that liver damage is frequently induced in patients on INH treatment. Thus, the toxicity of Hz and its derivatives is of great interest from the point of view of the side effects in INH therapy. Although the exact sequence of events leading ultimately to liver injury has not been fully elucidated, Timbrell et al. postulated that INH induced liver necrosis may be caused by a chemically reactive metabolite of INH, monoacetylhydrazine (AcHz).5) On the other hand, we found that Hz induced more marked hepatic injury than AcHz, and analogous but more extensive necrosis took place after Hz administration to rabbits pretreated with an inducer of cytochrome P-450 [phenobarbital (PB) or rifampicin (RMP)].6) Liver function tests and histological studies indicated similar liver injury in rats to that in rabbits.7) We also found that the liver and plasma concentrations of Hz in both animals after the intraperitoneal injection of INH were almost the same as those of AcHz.8) In the pretreated rats, the liver and plasma Hz concentrations were considerably lower than those of the control group, but this was not the case with AcHz.
These facts prompted us to compare the cytotoxicities of Hz and AcHz using an isolated rat hepatocyte system. The previous experiments showed that the incubation of Hz and AcHz in isolated rat hepatocytes induced marked concentration-dependent cell death, as indicated by a trypan blue exclusion test9) This test did not show a distinct difference between Hz and AcHz in terms of the extent of cell injury. However, our prelimipary investigations have also shown that a significant time-and concentration-dependent depletion of hepatocellular reduced glutathione (GSH) levels was induced by Hz treatment, while AcHz caused very little GSH depletion.9)
The data suggest that a key step of Hz metabolism produces the toxic intermediate(s). As the ultimate metabolite of Hz is known to be nitrogen (N2),10) the induction of hepatotoxicity by Hz may be due to a metabolic intermediate formed during the microsomal oxidation process. Recently, we reported that Hz metabolism in rat liver microsomal fractions resulted in the formation of Hz radical and diimide.11,12) Therefore, in order to clarify the relationship of Hz metabolism to its hepatotoxicity, the present examination was designed to explore the toxic effects of Hz on isolated rat cells. Results and Discussion Figure 1 shows the time course of Hz disappearance after the incubation of 0.1 mm Hz with hepatocytes isolated from intact, PB-or RMP-pretreated rats. After incubation for 60 min with hepatocytes from the untreated group, the Hz concentration had decreased to 34% of the initial value (from 98 to 33 nmol/ml), while the Hz levels after 60 min with hepatocytes from PB-and RMP-pretreated rats were 21% and 29% of the initial value, respectively (significantly different from the untreated group). The half-lives of Hz disappearance were calculated as 0.71 h for the control group, 0.47 h for the PB-pretreated group and 0.60 h for the RMP-pretreated one. The significant decrease in the latter two cases can be reasonably explained in terms of the increase of the hepatic cytochrome P-450,16) since the main metabolic pathway of Hz is cytochrome P-450 dependent oxidation. 10) In the previous study in vivo, we observed that the elimination rate of Hz was significantly increased in PB-and RMP-pretreated rats after intravenous administration.8) In order to clarify the metabolic course of Hz, the effects of metyrapone and piperonylbutoxide, potent inhibitors of cytochrome P-450, were investigated using isolated rat liver cells. As shown in Fig. 2A , the decrease of Hz in the hepatocytes obtained from the control group was retarded by piperonylbutoxide addition (0.1 mm), while metyrapone (1.0 mm) did not have a significant effect. The difference between the inhibitory effects of these treatments may result from a difference in the extents of hepatocyte uptake of the respective compounds or inhibition of a specific isozyme of cytochrome P-450 which participates in the Hz oxidation. Figure 2B shows the effect of metyrapone on Hz disappearance in heaptocytes isolated from PB-pretreated rats pretreatment had a marked effect on the toxicity, while RMP pretreatment had only a slight effect. Therefore, the concentration dependence of the toxic effects of Hz was examined and compared with that of AcHz. Since the results showed that the cell viability and the amount of K + were reduced concentration-dependently by both Hz's (Fig. 5) , cytotoxicity was demonstrated. However, no difference of cytotoxicity could be seen between Hz and AcHz. The intracellular GSH content was significantly decreased not only with increasing Hz concentrations in the mixture but also with increasing incubation time with the hepatocytes isolated from both PB-and RMP-pretreated rats (Fig. 6) . We observed no significant increase in the formation of GSSG, as shown in Table I . A similar tendency was reported by Watanabe In conclusion, Hz and AcHz are cytotoxic to isolated hepatocytes and the initial stage of the toxic response appears to involve damage to the cell membrane, as described by Siemens et al. 19 ) The experiments using the hepatocyte system probably mimic quite well the in vivo characteristics of Hz toxicity in the liver. 
